RARobert Douglas Anderson

Robert Douglas Anderson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert Douglas Anderson has a total of 124 co-authors. Here are the top co-authors by number of shared publications:

  • Geoffrey Lee

    Department of Cardiology, Royal Melbourne Hospital, Parkville, VIC, Australia

    10 shared publications
  • Jonathan M. Kalman

    Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Baker Heart and Diabetes Institute, Melbourne, Australia

    6 shared publications
  • Saurabh Kumar

    Department of Cardiology, Westmead Hospital, Westmead Applied Research Centre, University of Sydney, Westmead, Australia

    6 shared publications
  • Troy Watts

    Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Victoria, Australia

    6 shared publications
  • Geoffrey Lee

    Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Victoria, Australia

    5 shared publications
  • Joshua Hawson

    Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia

    4 shared publications

Latest Publications

  • Short‐Term Procedural Outcomes of Posterior Wall Isolation Using the Affera Pulse Field Ablation System

    by Udit Thakur, Jasper Junker, Youlin Koh, Sohaib Virk, Souvik Kumar Das, Danlu Liang, Bhupesh Pathik, Paul B. Sparks, Alex McLellan, Joseph Morton, et al.

    Background: Posterior wall isolation (PWI) is often added to pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF) and at redo ablation. Still, procedural performance with the Affera pulsed field ablation (PFA) platform is not well described. Methods: We retrospectively analyzed consecutive patients who underwent PWI with the Affera Sphere‐9 lattice‐tip catheter from April to August 2025. Baseline characteristics and procedural data, including PWI time, number of lesions, and acute success, were analyzed. The primary procedural endpoint was acute PWI success. Secondary measures included time to PWI, number of applications, posterior wall area isolated, and complications. Results: Forty patients underwent PWI (paroxysmal AF 13 [32.5%], persistent AF 27 [67.5%]). First pass PWI was achieved in 97.5%; overall acute PWI success was 100%. Median time to complete PWI was 7.0 min (IQR 5.1–11.0). Mean lesions for PWI were 19.6 ± 6.6, and the mean posterior wall area isolated was 12.9 ± 4.5 cm². Two minor vascular complications occurred (5.0%): one acute and one delayed femoral hematoma, both managed conservatively. After a median follow‐up of 76 [58.5–121] days, 38/40 (95%) patients remained free from atrial arrhythmia. Conclusions: PWI with the Affera Sphere‐9 system achieved 97.5% first‐pass isolation with rapid, consistent procedural times. Further study of lesion durability and clinical outcomes is warranted.

  • Isochronal Apparent Dispersion at Early Activation Sites Accurately Identifies Outflow Tract Ventricular Ectopy Sites

    by Robert D. Anderson, Stephane Masse, Joshua Hawson, Geoffrey Lee, Mukund Prabhu, Abhishek Bhaskaran, Andrew C.T. Ha, Krishnakumar Nair, Vijay Chauhan, Kumaraswamy Nanthakumar


  • Left Ventricular Summit Arrhythmias

    by Souvik K. Das, Joshua Hawson, Youlin Koh, Michael W. Lim, Paolo D'AMbrosio, Sohaib A. Virk, Danlu Liang, Troy Watts, Jairo Rodriguez Padilla, Kumaraswamy Nanthakumar, et al.


  • Open Access

    Spontaneous termination of ventricular tachycardia in the human heart

    by Takahiro Hayashi, Nathan Denham, Chloe Nettlefold, Jayant Kakarla, Robert Anderson, Abhishek Bhaskaran, Stéphane Massé, Eugene Downar, Kumaraswamy Nanthakumar

    Introduction: Understanding the spatiotemporal location of the spontaneous termination of ventricular tachycardia (VT) may provide new insights for ablation. To test the hypothesis that spontaneous VT termination most frequently occurs at the VT exit due to source‐sink mismatch and to characterize electrophysiological properties of the sites termination during VT and with extra‐stimulus technique.Methods: Retrospective analysis of intraoperative mapping studies of nine patients with ischemic cardiopathy or repaired tetralogy of Fallot. Simultaneous endocardial and epicardial mapping was performed in both ventricles using a custom mapping array during VT. Electrogram (EGM) characteristics before and at the moment of termination were analyzed including: cycle length oscillations, EGM heterogeneity and a variation in the systolic/diastolic path. The decrements to extra stimulus were analysed for termination sites and other diastolic sites.Results: Nine VTs in seven patients demonstrated spontaneous VT termination. Seven VTs (77.8%) spontaneously terminated in the final third of the systolic interval, one (11.1%) in early diastole and one (11.1%) in mid diastole. Cycle length oscillations (prolongation, shortening, and no change) were seen in equal frequency. Four VTs (44.4%) showed alternans in the local EGM at the site of termination and this was more prevalent than alternans at other sites in the diastolic pathway (p < .001). Only one‐third of VTs showed a change in activation pattern before termination. There was no difference based on etiology. During substrate characterization with extra‐stimulus pacing, sites of spontaneous termination showed greater decrement than other sites of the VT circuit during pacing (43.5 ± 14.5 ms vs. 31.2 ± 31.2 ms; p = .003).Conclusion: The entrance zone rather than the exit is the commonest site for the spontaneous termination of VT in the human heart. These sites tend to demonstrate EGM alternans during VT and greater decrement during extrastimulus pacing. These findings may help guide future studies into improving the success of VT ablation.

  • Two ripples in a pond: The subtleties of mapping observations in localizing premature ventricular complex sites

    by Robert D. Anderson, Abhishek Bhaskaran, Andrew C. T. Ha, Kumaraswamy Nanthakumar

  • Open Access

    Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences

    by Jonathan M Kalman, Ahmed M Al-Kaisey, Ramanathan Parameswaran, Joshua Hawson, Robert D Anderson, Michael Lim, David Chieng, Stephen A Joseph, Alex McLellan, Joseph B Morton, et al.

    Background: Catheter ablation is an effective strategy in atrial fibrillation (AF). However, its timing in the course of management remains unclear. The aim of this study was to determine if an early vs. delayed AF ablation strategy is associated with differences in arrhythmia outcomes during 12-month follow-up. Methods and results: One hundred patients with symptomatic AF referred to a tertiary centre for management were randomized in a 1:1 ratio to either an early ablation strategy (within 1 month of recruitment) or a delayed ablation strategy (optimized medical therapy followed by catheter ablation at 12 months post recruitment). The primary endpoint was atrial arrhythmia free survival at 12 months post-ablation. Secondary outcomes included: (i) AF burden, (ii) AF burden by AF phenotype, and (iii) antiarrhythmic drug (AAD) use at 12 months. Overall, 89 patients completed the study protocol (Early vs. Delayed: 48 vs. 41). Mean age was 59 ± 12.9 years (29% women). Pulmonary vein isolation was achieved in 100% of patients. At 12 months, 56.3% of patients in the early ablation group were free from recurrent arrhythmia, compared with 58.6% in the delayed ablation group (HR 1.12, 95% CI 0.59–2.13, P = 0.7). All secondary outcomes showed no significant difference including median AF burden (Early vs. Delayed: 0% [IQR 3.2] vs. 0% [5], P = 0.66), median AF burden amongst paroxysmal AF patients (0% [IQR 1.1] vs. 0% [4.5], P = 0.78), or persistent AF patients (0% [IQR 22.8] vs. 0% [5.6], P = 0.45) or AAD use (33% vs. 37%, P = 0.8). Conclusion: Compared with an early ablation strategy, delaying AF ablation by 12 months for AAD management did not result in reduced ablation efficacy.


  • Open Access

    Utility of cardiac imaging in patients with ventricular tachycardia

    by Joshua Hawson, Subodh Joshi, Ahmed Al-Kaisey, Souvik K. Das, Robert D. Anderson, Joseph Morton, Saurabh Kumar, Peter Kistler, Jonathan Kalman, Geoffrey Lee


  • Open Access

    Orientation of conduction velocity vectors on cardiac mapping surfaces

    by Jairo Rodriguez Padilla, Robert D Anderson, Christian Joens, Stephane Masse, Abhishek Bhaskaran, Ahmed Niri, Patrick Lai, Mohammed Ali Azam, Geoffrey Lee, Edward Vigmond, et al.

    Electroanatomical maps using automated conduction velocity (CV) algorithms are now being calculated using two-dimensional (2D) mapping tools. We studied the accuracy of mapping surface 2D CV, compared to the three-dimensional (3D) vectors, and the influence of mapping resolution in non-scarred animal and human heart models. Two models were used: a healthy porcine Langendorff model with transmural needle electrodes and a computer stimulation model of the ventricles built from an MRI-segmented, excised human heart. Local activation times (LATs) within the 3D volume of the mesh were used to calculate true 3D CVs (direction and velocity) for different pixel resolutions ranging between 500 μm and 4 mm (3D CVs). CV was also calculated for endocardial surface-only LATs (2D CV). In the experimental model, surface (2D) CV was faster on the epicardium (0.509 m/s) compared to the endocardium (0.262 m/s). In stimulation models, 2D CV significantly exceeded 3D CVs across all mapping resolutions and increased as resolution decreased. Three-dimensional and 2D left ventricle CV at 500 μm resolution increased from 429.2 ± 189.3 to 527.7 ± 253.8 mm/s (P < 0.01), respectively, with modest correlation (R = 0.64). Decreasing the resolution to 4 mm significantly increased 2D CV and weakened the correlation (R = 0.46). The majority of CV vectors were not parallel (<30°) to the mapping surface providing a potential mechanistic explanation for erroneous LAT-based CV over-estimation. Ventricular CV is overestimated when using 2D LAT-based CV calculation of the mapping surface and significantly compounded by mapping resolution. Three-dimensional electric field-based approaches are needed in mapping true CV on mapping surfaces. Leftward panel: Orientation vectors projecting from a basal view of the endocardium (blue, 3D true CV and pink, 2D CV). Top rightward panel: 3D and 2D CV vector parallel (30° in red). Bottom rightward panel: Distribution histogram showing increased 2D CV (pink) compared to the 3D CV (blue). 2D, two-dimensional; 3D, three-dimensional; CV, conduction velocity; EAM, electroanatomical mapping; EGM, electrogram; LAT, local activation time; LV, left ventricle; RV, right ventricle; VT, ventricular tachycardia